Covid-19 News

Meet the Israeli Tech Companies Fighting COVID-19 Head-On

OurCrowd Portfolio Companies Pivot to Tackle Coronavirus Pandemic

MeMed to predict which COVID-19 patients will worsen

 

Media Coverage

Test aiming to provide better treatment decisions receives CE mark

MeMed Ramping Up Commercialization Efforts Following Regulatory Approvals

MeMed Receives CE for Advanced Diagnostic Test

MeMed Receives CE-IVD Mark for Infectious Disease Test

Calcalist logo.png

MeMed Receives Regulatory Green Light for Test 

World-Economic-Forum-Logo.png

MeMed Named "Technology Pioneer" by World Economic Forum

US DoD Commits Additional Funds to MeMed's Innovative Bacterial Versus Viral Test

The journey towards a disruptive blood test that can help address the threat of antibiotic resistance

Rapid blood test to 'cut antibiotic use'

FierceBiotechLogoNew.png

MeMed raises $70M for immune system-based infection diagnostics

MeMed Publishes New Data on Infectious Disease Dx, Plans 2018 Launch of POC Test

MeMed swiftly diagnoses if a disease is viral or bacterial 

MeMed raises $70M

New study shows MeMed's blood test accurately distinguishes bacterial and viral infections

Infectious Disease Detective

MeMed Using $70M Funding Round to Develop Infection Test and POC Platform

Israeli infection diagnostic start-up wins $9.2M funding boost

MeMed has received a contract from the Defense Threat Reduction Agency

Viruses from Mars, bacteria from Venus

MeMed Rolling Out Proteomic Test to Distinguish Between Bacterial, Viral Infections

MeMed Wins $9.2M DTRA Contract for PoC IVD to Reduce Antibiotic Misuse

A new blood test could stop doctors from over prescribing antibiotics

New Study Shows Superiority of MeMed's ImmunoXpert™ Over Procalcitonin, CRP, and HNL

Press Releases

 

News

Dec 5, 2018

ECCMID 2018 - 23/04/2018 09:00 am, Hall F

19 Apr, 2017

Listen to a podcast with Dr. Kfir Oved

Full list (Hebrew)

Dec 21, 2016

MeMed's CEO will talk about Opportunities and Challenges in Personalized Diagnostics at the annual IATI Biomed conference, on May 25, Tel-Aviv, Israel.

IATI Biomed 2016

MeMed will host a round table of leading European pediatricians at this year"s ESPID, to discuss new strategies of using host-response based diagnostics for reducing antibiotic misuse

ESPID 2016

MeMed Joins the CDC's Initiative for Addressing Antibiotic Resistance.

Nov 16, 2015